Details for Patent: 5,866,591
✉ Email this page to a colleague
Summary for Patent: 5,866,591
| Title: | Stable formulations of remifentanil |
| Abstract: | Stable formulations of 3-[4-methoxycarbonyl-4-[(1 -oxopropyl)phenylamino]-1-piperidine]propanoic acid, methyl ester, generally referred to as remifentanil, are disclosed. In particular, stabilized lyophilized solid composition are disclosed comprising certain acids, most preferably comprising glycine. |
| Inventor(s): | Gatlin; Larry Alan (Chapel Hill, NC), Heiman; Shirley Ann (Cary, NC), Lewis; Janet Sue (Cary, NC) |
| Assignee: | Glaxo Wellcome Inc. (Research Triangle Park, NC) |
| Application Number: | 08/926,930 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 5,866,591
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
